Cargando…
Correction to: Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070610/ https://www.ncbi.nlm.nih.gov/pubmed/35513761 http://dx.doi.org/10.1007/s12185-022-03376-y |
| _version_ | 1784700677908332544 |
|---|---|
| author | Inaba, Tohru Okumura, Keita Maekura, Chika Muramatsu, Ayako Kobayashi, Tsutomu Kuroda, Junya Nukui, Yoko |
| author_facet | Inaba, Tohru Okumura, Keita Maekura, Chika Muramatsu, Ayako Kobayashi, Tsutomu Kuroda, Junya Nukui, Yoko |
| author_sort | Inaba, Tohru |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9070610 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Nature Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90706102022-05-06 Correction to: Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination Inaba, Tohru Okumura, Keita Maekura, Chika Muramatsu, Ayako Kobayashi, Tsutomu Kuroda, Junya Nukui, Yoko Int J Hematol Correction Springer Nature Singapore 2022-05-05 2022 /pmc/articles/PMC9070610/ /pubmed/35513761 http://dx.doi.org/10.1007/s12185-022-03376-y Text en © Japanese Society of Hematology 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correction Inaba, Tohru Okumura, Keita Maekura, Chika Muramatsu, Ayako Kobayashi, Tsutomu Kuroda, Junya Nukui, Yoko Correction to: Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination |
| title | Correction to: Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination |
| title_full | Correction to: Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination |
| title_fullStr | Correction to: Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination |
| title_full_unstemmed | Correction to: Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination |
| title_short | Correction to: Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination |
| title_sort | correction to: patients with b-cell lymphoma receiving anti-cd20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to covid-19 vaccination |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070610/ https://www.ncbi.nlm.nih.gov/pubmed/35513761 http://dx.doi.org/10.1007/s12185-022-03376-y |
| work_keys_str_mv | AT inabatohru correctiontopatientswithbcelllymphomareceivinganticd20monoclonalantibodycontainingchemotherapiesandseroreactivepatternsinresponsetocovid19vaccination AT okumurakeita correctiontopatientswithbcelllymphomareceivinganticd20monoclonalantibodycontainingchemotherapiesandseroreactivepatternsinresponsetocovid19vaccination AT maekurachika correctiontopatientswithbcelllymphomareceivinganticd20monoclonalantibodycontainingchemotherapiesandseroreactivepatternsinresponsetocovid19vaccination AT muramatsuayako correctiontopatientswithbcelllymphomareceivinganticd20monoclonalantibodycontainingchemotherapiesandseroreactivepatternsinresponsetocovid19vaccination AT kobayashitsutomu correctiontopatientswithbcelllymphomareceivinganticd20monoclonalantibodycontainingchemotherapiesandseroreactivepatternsinresponsetocovid19vaccination AT kurodajunya correctiontopatientswithbcelllymphomareceivinganticd20monoclonalantibodycontainingchemotherapiesandseroreactivepatternsinresponsetocovid19vaccination AT nukuiyoko correctiontopatientswithbcelllymphomareceivinganticd20monoclonalantibodycontainingchemotherapiesandseroreactivepatternsinresponsetocovid19vaccination |